MedTrace Logo

Proprioceptive Training,Balance,Motor Function,Spastic Cerebral Palsy Patient

NCT05252169 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2022-03-17

No results posted yet for this study

Summary

Study Design: Randomized Controlled Trial Settings: Study will be conducted at Mobility quest clinic, Lahore Sample size:37 in each group Control group receive : Routine physical therapy Experimental group receive : Routine physical therapy+proprioceptive training

Conditions

  • Hemiplegic Cerebral Palsy

Interventions

OTHER

Proprioceptive training

Proprioceptive Training will include some active exercises such as stair climbing up and down,one leg standing,Walking heel to toes,rising from a standard chair. And swiss ball training will be applied passively by therapist in which child will sit on the ball and ball will be rolled from side to side,Extension rotation and flexion rotation will be performed to facilitate trunk rotation,Trunk rotation will be performed with stabilized pelvis and hip.

OTHER

Routine Physical therapy

Group A will be given routine physical therapy which will be of 60 minutes each session. The routine physical therapy will include * Passive stretching exercises * Weight bearing exercises * Functional strength training Duration of the treatment will be 3 days a week for 12 weeks i.e., 36 sessions. Each session will be of 60 minutes.

Sponsors & Collaborators

  • University of Lahore

    lead OTHER

Principal Investigators

  • Kinza Amin, MSPTN* · Univerity of Lahore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-23
Primary Completion
2022-08-16
Completion
2022-08-26

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05252169 on ClinicalTrials.gov